Serial #79201092
LIVE

Serial Number

79201092

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Sep 5, 2016

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79201092 Trademark

Serial Number: 79201092 • Registration: 5238870

Serial #79201092 is a trademark filed by NOVARTIS AG on September 5, 2016. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,166 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

September 5, 2016

Registration Date

July 11, 2017

Published for Opposition

April 25, 2017

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; [ pharmaceutical preparations for the prevention and treatment of cancer and tumors; ] pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

INTERNATIONAL REGISTRATION RENEWED
Sep 14, 2023 RNWL
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Aug 26, 2023 NA75
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Aug 26, 2023 C75A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Aug 15, 2023 APRE
TEAS SECTION 71 & 15 RECEIVED
Jan 31, 2023 ES75
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jul 11, 2022 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Nov 3, 2017 FINV
FINAL DISPOSITION NOTICE SENT TO IB
Oct 16, 2017 FICS
FINAL DISPOSITION PROCESSED
Oct 16, 2017 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 11, 2017 FICR
REGISTERED-PRINCIPAL REGISTER
Jul 11, 2017 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 25, 2017 NPUB
PUBLISHED FOR OPPOSITION
Apr 25, 2017 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 5, 2017 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 17, 2017 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 17, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 16, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 16, 2017 TROA
REFUSAL PROCESSED BY IB
Mar 10, 2017 RFNT
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 4, 2017 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 4, 2017 REAP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 21, 2017 RFCS
REFUSAL PROCESSED BY MPU
Feb 21, 2017 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 17, 2017 RFCR
NON-FINAL ACTION WRITTEN
Feb 16, 2017 CNRT
APPLICATION FILING RECEIPT MAILED
Feb 14, 2017 MAFR
ASSIGNED TO EXAMINER
Feb 8, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 8, 2017 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Feb 6, 2017 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Feb 2, 2017 SDRC